Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David DiGiusto

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cytotherapy|October 7, 2011
Implementation of a configurable laboratory information management system for use in cellular process development and manufacturingDiana Russom, Amira Ahmed, Nancy Gonzalez, et al.
Leukemia & Lymphoma|March 5, 2003
Hematopoietic potential of neural stem cells: plasticity versus heterogeneityChu-chih Shih, David DiGiusto, Adam Mamelak, et al.
Stem Cells and Development|November 15, 2007
Human marrow-derived mesodermal progenitor cells generate insulin-secreting islet-like clusters in vivoCuiwei Ai, Ivan Todorov, Marilyn L Slovak, et al.
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
T-cell genetic modification for re-directed tumor recognitionLaurence J N Cooper, Michael Kalos, David DiGiusto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humansMichael C Jensen, Leslie Popplewell, Laurence J Cooper, et al.
Blood Cells, Molecules & Diseases|June 30, 2004
Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignanciesLaurence J N Cooper, Zaid Al-Kadhimi, David DiGiusto, et al.
Stem Cells Translational Medicine|December 1, 2012
Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriationChy-Anh Tran, Monica Torres-Coronado, Agnes Gardner, et al.
Cancer Research|April 28, 2011
STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphomaAnna Scuto, Maciej Kujawski, Claudia Kowolik, et al.
Systematic Reviews|June 28, 2017
An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocolDavid Pettitt, Zeeshaan Arshad, Benjamin Davies, et al.
Science (New York, N.Y.)|October 27, 2018
Protect NIH's DNA advisory committeeZach N Adelman, Lorraine M Albritton, Kathleen Boris-Lawrie, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cytotherapy|October 7, 2011
Implementation of a configurable laboratory information management system for use in cellular process development and manufacturingDiana Russom, Amira Ahmed, Nancy Gonzalez, et al.
Leukemia & Lymphoma|March 5, 2003
Hematopoietic potential of neural stem cells: plasticity versus heterogeneityChu-chih Shih, David DiGiusto, Adam Mamelak, et al.
Stem Cells and Development|November 15, 2007
Human marrow-derived mesodermal progenitor cells generate insulin-secreting islet-like clusters in vivoCuiwei Ai, Ivan Todorov, Marilyn L Slovak, et al.
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
T-cell genetic modification for re-directed tumor recognitionLaurence J N Cooper, Michael Kalos, David DiGiusto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 23, 2010
Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humansMichael C Jensen, Leslie Popplewell, Laurence J Cooper, et al.
Blood Cells, Molecules & Diseases|June 30, 2004
Development and application of CD19-specific T cells for adoptive immunotherapy of B cell malignanciesLaurence J N Cooper, Zaid Al-Kadhimi, David DiGiusto, et al.
Stem Cells Translational Medicine|December 1, 2012
Optimized processing of growth factor mobilized peripheral blood CD34+ products by counterflow centrifugal elutriationChy-Anh Tran, Monica Torres-Coronado, Agnes Gardner, et al.
Cancer Research|April 28, 2011
STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphomaAnna Scuto, Maciej Kujawski, Claudia Kowolik, et al.
Systematic Reviews|June 28, 2017
An assessment of the factors affecting the commercialization of cell-based therapeutics: a systematic review protocolDavid Pettitt, Zeeshaan Arshad, Benjamin Davies, et al.
Science (New York, N.Y.)|October 27, 2018
Protect NIH's DNA advisory committeeZach N Adelman, Lorraine M Albritton, Kathleen Boris-Lawrie, et al.
Pageof 2